» Articles » PMID: 25366964

Adiposity Induces Lethal Cytokine Storm After Systemic Administration of Stimulatory Immunotherapy Regimens in Aged Mice

Abstract

Aging is a contributing factor in cancer occurrence. We recently demonstrated that systemic immunotherapy (IT) administration in aged, but not young, mice resulted in induction of rapid and lethal cytokine storm. We found that aging was accompanied by increases in visceral fat similar to that seen in young obese (ob/ob or diet-induced obese [DIO]) mice. Yet, the effects of aging and obesity on inflammatory responses to immunotherapeutics are not well defined. We determine the effects of adiposity on systemic IT tolerance in aged compared with young obese mice. Both young ob/ob- and DIO-generated proinflammatory cytokine levels and organ pathologies are comparable to those in aged ad libitum mice after IT, culminating in lethality. Young obese mice exhibited greater ratios of M1/M2 macrophages within the peritoneal and visceral adipose tissues and higher percentages of TNF(+) macrophages in response to αCD40/IL-2 as compared with young lean mice. Macrophage depletion or TNF blockade in conjunction with αCD40/IL-2 prevented cytokine storms in young obese mice and protected from lethality. Calorie-restricted aged mice contain less visceral fat and displayed reduced cytokine levels, protection from organ pathology, and protection from lethality upon αCD40/IL-2 administration. Our data demonstrate that adiposity is a critical factor in the age-associated pathological responses to systemic anti-cancer IT.

Citing Articles

Improving bench-to-bedside translation for acute graft-versus-host disease models.

McDaniel Mims B, Furr K, Enriquez J, Grisham M Dis Model Mech. 2025; 18(2).

PMID: 40019007 PMC: 11892683. DOI: 10.1242/dmm.052084.


Facing stress and inflammation: From the cell to the planet.

Cavaillon J, Chaudry I World J Exp Med. 2024; 14(4):96422.

PMID: 39713080 PMC: 11551703. DOI: 10.5493/wjem.v14.i4.96422.


Potential roles of sex-linked differences in obesity and cancer immunotherapy: revisiting the obesity paradox.

Vick L, Rosario S, Riess J, Canter R, Mukherjee S, Monjazeb A NPJ Metab Health Dis. 2024; 2(1):5.

PMID: 38800540 PMC: 11116109. DOI: 10.1038/s44324-024-00007-4.


Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?.

Canter R, Judge S, Collins C, Yoon D, Murphy W J Immunother Cancer. 2024; 12(3).

PMID: 38485185 PMC: 10941146. DOI: 10.1136/jitc-2023-008443.


A comprehensive review on immune checkpoint inhibitors induced cardiotoxicity characteristics and associated factors.

Ndjana Lessomo F, Mandizadza O, Mukuka C, Wang Z Eur J Med Res. 2023; 28(1):495.

PMID: 37941006 PMC: 10631013. DOI: 10.1186/s40001-023-01464-1.


References
1.
Balducci L, Ershler W . Cancer and ageing: a nexus at several levels. Nat Rev Cancer. 2005; 5(8):655-62. DOI: 10.1038/nrc1675. View

2.
Ronti T, Lupattelli G, Mannarino E . The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006; 64(4):355-65. DOI: 10.1111/j.1365-2265.2006.02474.x. View

3.
Vazquez-Vela M, Torres N, Tovar A . White adipose tissue as endocrine organ and its role in obesity. Arch Med Res. 2008; 39(8):715-28. DOI: 10.1016/j.arcmed.2008.09.005. View

4.
Spaulding C, WALFORD R, Effros R . Calorie restriction inhibits the age-related dysregulation of the cytokines TNF-alpha and IL-6 in C3B10RF1 mice. Mech Ageing Dev. 1997; 93(1-3):87-94. DOI: 10.1016/s0047-6374(96)01824-6. View

5.
Harris T . Invited commentary: body composition in studies of aging: new opportunities to better understand health risks associated with weight. Am J Epidemiol. 2002; 156(2):122-4; discussion 125-6. DOI: 10.1093/aje/kwf024. View